
Saskatchewan to enhance cancer treatment safety through genotyping
Global News
The Sask. government, SHA, and Saskatchewan Cancer Agency are launching a genome testing program to improve the safety of cancer patients receiving chemotherapy treatment.
Saskatchewan is launching a program to test the genomes of cancer patients who may face life-threatening side-effects from some chemotherapy drugs.
The test identifies genetic variants on a gene that affects the production of a certain enzyme.
Previously these tests were done in the U-S with a two-week turnaround time, but they would only take two to seven days once they can be done at the Royal University Hospital in Saskatoon.
The lab expects to test around one thousand patients a year.
More Related News













